112 related articles for article (PubMed ID: 11224654)
1. Directed modification instead of normalization of fatty acid patterns in cystic fibrosis: an emerging concept.
Christophe A; Robberecht E
Curr Opin Clin Nutr Metab Care; 2001 Mar; 4(2):111-3. PubMed ID: 11224654
[TBL] [Abstract][Full Text] [Related]
2. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
[TBL] [Abstract][Full Text] [Related]
3. Association of cystic fibrosis with abnormalities in fatty acid metabolism.
Freedman SD; Blanco PG; Zaman MM; Shea JC; Ollero M; Hopper IK; Weed DA; Gelrud A; Regan MM; Laposata M; Alvarez JG; O'Sullivan BP
N Engl J Med; 2004 Feb; 350(6):560-9. PubMed ID: 14762183
[TBL] [Abstract][Full Text] [Related]
4. An overview of monitoring and supplementation of omega 3 fatty acids in cystic fibrosis.
Coste TC; Armand M; Lebacq J; Lebecque P; Wallemacq P; Leal T
Clin Biochem; 2007 May; 40(8):511-20. PubMed ID: 17316592
[TBL] [Abstract][Full Text] [Related]
5. Relation between essential fatty acid metabolism and gastrointestinal symptoms in cystic fibrosis.
Strandvik B
Acta Paediatr Scand Suppl; 1989; 363():58-63; discussion 63-5. PubMed ID: 2701926
[TBL] [Abstract][Full Text] [Related]
6. Essential fatty acid deficiency in well nourished young cystic fibrosis patients.
Roulet M; Frascarolo P; Rappaz I; Pilet M
Eur J Pediatr; 1997 Dec; 156(12):952-6. PubMed ID: 9453380
[TBL] [Abstract][Full Text] [Related]
7. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis.
Al-Turkmani MR; Freedman SD; Laposata M
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(5-6):309-18. PubMed ID: 18036797
[TBL] [Abstract][Full Text] [Related]
8. Serum phospholipid fatty acid pattern is associated with bone mineral density in children, but not adults, with cystic fibrosis.
Gronowitz E; Mellström D; Strandvik B
Br J Nutr; 2006 Jun; 95(6):1159-65. PubMed ID: 16768839
[TBL] [Abstract][Full Text] [Related]
9. Elevated prostaglandin E metabolites and abnormal plasma fatty acids at baseline in pediatric cystic fibrosis patients: a pilot study.
O'Connor MG; Thomsen K; Brown RF; Laposata M; Seegmiller A
Prostaglandins Leukot Essent Fatty Acids; 2016 Oct; 113():46-49. PubMed ID: 27720040
[TBL] [Abstract][Full Text] [Related]
10. Fatty acid metabolism in cystic fibrosis.
Strandvik B
Prostaglandins Leukot Essent Fatty Acids; 2010 Sep; 83(3):121-9. PubMed ID: 20673710
[TBL] [Abstract][Full Text] [Related]
11. Fatty acids in cystic fibrosis.
Freedman SD; Shea JC; Blanco PG; Alvarez JG
Curr Opin Pulm Med; 2000 Nov; 6(6):530-2. PubMed ID: 11100964
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid imbalance might lead to novel treatments for CF.
Greener M
Mol Med Today; 2000 Feb; 6(2):47-8. PubMed ID: 10652475
[No Abstract] [Full Text] [Related]
13. Influence of pancreatic status and sex on polyunsaturated fatty acid profiles in cystic fibrosis.
Coste TC; Deumer G; Reychler G; Lebecque P; Wallemacq P; Leal T
Clin Chem; 2008 Feb; 54(2):388-95. PubMed ID: 18089657
[TBL] [Abstract][Full Text] [Related]
14. Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases.
Njoroge SW; Laposata M; Boyd KL; Seegmiller AC
J Nutr Biochem; 2015 Jan; 26(1):36-43. PubMed ID: 25448610
[TBL] [Abstract][Full Text] [Related]
15. Fatty acid metabolism in cystic fibrosis.
Strandvik B
N Engl J Med; 2004 Feb; 350(6):605-7. PubMed ID: 14762189
[No Abstract] [Full Text] [Related]
16. Effect of an 8-month treatment with omega-3 fatty acids (eicosapentaenoic and docosahexaenoic) in patients with cystic fibrosis.
De Vizia B; Raia V; Spano C; Pavlidis C; Coruzzo A; Alessio M
JPEN J Parenter Enteral Nutr; 2003; 27(1):52-7. PubMed ID: 12549599
[TBL] [Abstract][Full Text] [Related]
17. Current knowledge on fatty acids in cystic fibrosis.
Christophe A; Robberecht E
Prostaglandins Leukot Essent Fatty Acids; 1996 Sep; 55(3):129-38. PubMed ID: 8931108
[No Abstract] [Full Text] [Related]
18. Oral absorption of omega-3 fatty acids in patients with cystic fibrosis who have pancreatic insufficiency and in healthy control subjects.
Henderson WR; Astley SJ; McCready MM; Kushmerick P; Casey S; Becker JW; Ramsey BW
J Pediatr; 1994 Mar; 124(3):400-8. PubMed ID: 8120709
[TBL] [Abstract][Full Text] [Related]
19. Deficiencies of essential fatty acids and vitamin E in cystic fibrosis.
Böhles H; Heid H; Stehr K; Fekl W
Z Ernahrungswiss; 1979 Jul; 18(2):81-7. PubMed ID: 524930
[TBL] [Abstract][Full Text] [Related]
20. Relationships between pulmonary function and plasma fatty acid levels in cystic fibrosis patients.
Gibson RA; Teubner JK; Haines K; Cooper DM; Davidson GP
J Pediatr Gastroenterol Nutr; 1986; 5(3):408-15. PubMed ID: 3723260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
